BRCA2 and colorectal carcinoma: Consistently, in this study, the knockdown of BRCA2 reduced the resistance of CRC cells to olaparib (Figure 2D,E) and attenuated the effects on promoting BRCA2-induced HR repair of CRC cells (Figure 2B,C).